EUROPEAN COMMISSION-Horizon 2020 - Research and Innovation Framework Programme
Call: H2020-WIDESPREAD-2014-1-FPA-TEAMING 
eu flag 
The CY-Biobank project receives funding from the European Union's Horizon 2020 research and innovation programme under Grant Agreement No. 664561
 
Duration (months): 12                                                                 Budget: €460,638
             
 
We are excited to share our NEW CY-Biobank logo with you! 
 
cy-biobank logo
biobank

Welcome to the Molecular Medicine Research Center (MMRC), the first research center of the University of Cyprus (UCY) that aspires and aims at developing front-line research on inherited human diseases and offer better prospects for diagnosis, prevention and therapy.

Briefly, we wish to inform you that a research proposal we submitted to the European Commission with the code name "CY-Biobank", succeeded in funding through Stage 1 of the Horizon 2020-ΤΕΑΜΙΝG call. The aim of Stage 1 is to prepare a detailed Business Plan in which we will describe our research goals and that is going to be submitted again to the European Commission for the Stage 2 evaluation, asking for up to 10 mi euro. The idea of our project concerns the upgrading of the MMRC that we started 4 years ago, into a Center of Excellence. We have achieved great progress in Biobanking in Cyprus, especially in the field of inherited kidney disorders, but a lot more needs to be done in order to better serve the Cypriot and European citizens.

See also: http://www.ucy.ac.cy/mmrc/en/

Prof. Constantinos Deltas
Project Coordinator
Director, Molecular Medicine Research Center